Navigation Links
TREATMENT OF PRIMARY LIVER CANCER: SARAH STUDY NOW AVAILABLE FOR ALL ELIGIBLE PATIENTS THROUGHOUT FRANCE
Date:6/24/2013

PARIS, June 24, 2013 /PRNewswire/ --

Launched by the Assistance Publique - Hôpitaux de Paris (AP-HP) in December 2011, SARAH, a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma seeks to enroll 400 patients

To date, more than 150 patients have taken part in this study

PARIS (June 20, 2013) In patients with advanced HCC, sorafenib (Nexavar®, Bayer HealthCare Pharmaceuticals, Germany), with which radioembolization is being compared, is now the standard treatment.  Its use is associated with an increased median overall survival (from 8 to 11 months in the SHARP trial) but 80% of patients also experience treatment-related adverse events. The SARAH trial is testing the hypothesis that radioembolization using yttrium-90 resin microspheres (SIR-Spheres® microspheres; Sirtex Medical Limited, Australia) can increase the median overall survival with fewer side effects and/or a better quality of life in comparison with sorafenib.

     (Logo: http://photos.prnewswire.com/prnh/20130620/622575)

Coordinated at the national level by Professor Valérie Vilgrain MD, PhD (Department of Radiology, Beaujon Hospital, AP-HP) - Principal Investigator of this large study, 19 specialist cancer centres throughout France (Angers, Bondy, Bordeaux, Caen, Clichy, Créteil, Dijon, Grenoble, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Poitiers, Saint Etienne, Strasbourg, Villejuif; cf. http://cli
'/>"/>

SOURCE SARAH trialists
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ... Oxygen Systems - Global Strategic Business Report" report ... worldwide markets for Medical Oxygen Systems in US$ Thousands ... Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The ... Canada , Japan , ...
(Date:4/17/2015)... 2015 Today, the Pharmaceutical Research and ... 12 biopharmaceutical companies as "We Work For Health ... and community service. Established in 2009, ... created by the biopharmaceutical industry to honor employees ... but have also shown an outstanding commitment to ...
(Date:4/17/2015)... , Apr. 16, 2015 Research and ... the addition of the "The Corporate Reputation ... - Global Edition " report to their ... a Patient Perspective, is now in its fourth ... results; published early 2015). For each annual Corporate ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... EF Johnson Technologies, Inc. (Nasdaq: EFJI ), a ... results for the quarter ended September 30, 2009. Revenues ... was $1.6 million, or $(0.06) per diluted share, for the ... pleased with our orders and contract awards, the third quarter ...
... Inc. (NYSE: ZMH ; SIX: ZMH) announced today that ... unsecured notes in an underwritten public offering consisting of $500.0 ... 5.75% notes due 2039. The 10-year notes were priced to ... 30-year notes were priced at 135 basis points above their ...
Cached Medicine Technology:EF Johnson Technologies Announces Third Quarter Results 2EF Johnson Technologies Announces Third Quarter Results 3EF Johnson Technologies Announces Third Quarter Results 4EF Johnson Technologies Announces Third Quarter Results 5EF Johnson Technologies Announces Third Quarter Results 6EF Johnson Technologies Announces Third Quarter Results 7EF Johnson Technologies Announces Third Quarter Results 8Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes 2
(Date:4/19/2015)... 19, 2015 Autocarinsurancecheap.com has released a ... can offer financial protection for vulnerable family members. ... the insured dies or is disabled in an accident. ... commonly bought with an auto insurance plan. However, AD&D ... similar to a life insurance policy. The newly blog ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 Broccoli sprout ... tolerable in a small group of healthy human volunteers, ... partner with UPMC CancerCenter , announced today at ... Annual Meeting in Philadelphia. , The promising results ... which will recruit participants at high risk for head ...
(Date:4/19/2015)... April 19, 2015 Lowcostcarinsuranceprice.com has ... of pills can get drivers arrested for DUI. The ... auto insurance premiums . , Some pills ... to driver properly. Drivers who are under medication should ... effects of certain pills can be considered driving under ...
(Date:4/19/2015)... 2015 Insurancecarsinsurance.com has released a new ... explaining how bad weather can affect auto insurance ... big impact on auto insurance premiums. In some Northern ... prices are higher than in other parts. The newly ... during the next several months and what impact, if ...
(Date:4/19/2015)... WASHINGTON, DC (PRWEB) April 19, 2015 ... again teaming up with PROSHRED Security (“PROSHRED”) to host ... are invited to shred their personal documents in order ... about cancer prevention. , The June 6th event is ... from 8am – 2pm local time. The time will ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Preventing Cancer with Broccoli Sprout Extract 2Health News:Preventing Cancer with Broccoli Sprout Extract 3Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:2015 Annual Nationwide "Shred Cancer" Shredding Event 2
... , RALEIGH, N.C., Nov. 16 Blue Water Spa, a Raleigh ... Raleigh with an anniversary party and Raleigh food drive. Guests who ... One lucky winner will receive a $10,000 spa gift certificate for ... of NC will be on hand Wed. November 18 and Saturday ...
... SINGAPORE, Nov. 16 /PRNewswire-Asia/ -- Retail ... steadily in the first half of 2009 with,total consumption peaking ... major Contact Lens manufacturers. Positive sales,data showing a growth of ... an economic recovery that is being led by consumers spending. ...
... every household has some sort of a first aid kit filled ... plan ahead for dental emergencies? , According to a recent ... products, although one in six Americans had a dental emergency during ... the problem. , "You keep medical supplies on hand for ...
... ... it says there is no solidity or separation, as commonly understood, between any physical ... religion, economics; and create world peace, eternal life and time travel. , ... (PRWEB) November 16, 2009 -- This is intended ...
... ... impairments caused by Alzheimer,s disease, Traumatic Brain Injury, ADD, Schizophrenia and more. , ... (PRWEB) November 16, 2009 ... rehab tools for a variety of cognitive disorders at the American Medical Informatics ...
... ... Science’s “Best of What’s New” in 2009 for their HyGreen™ hand washing system. ... Sarasota, FL ... Science’s “Best of What’s New” in 2009 for their HyGreen™ hand washing system. Xhale, ...
Cached Medicine News:Health News:Raleigh Day Spa, Blue Water Spa, Raffles Off $10,000 in Day Spa Packages for Contributing to Raleigh Food Drive 2Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 2Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 3Health News:Be Prepared for a Dental Emergency During the Holidays 2Health News:New View Of Reality (In Printed Book Form) That Combines Einstein And Quantum Mechanics, And Fills The World With Miracles 2Health News:New View Of Reality (In Printed Book Form) That Combines Einstein And Quantum Mechanics, And Fills The World With Miracles 3Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 3Health News:Xhale Recognized in Popular Science's "Best of What's New" with hand from ROBRADY design 2
ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
... The DRS 2000, a uniquely intelligent system, ... its space saving, 2-level design. Up to 27 ... to give you the flexibility to tailor your ... lab. Two start stations allow for continuous loading; ...
... latest from the leader in automatic slide ... modern approach to slide staining, ending messy ... blood smears, bone marrow and other body ... Aerospray stainer becomes a superb cytocentrifuge with ...
Medicine Products: